Susceptibility patterns of Streptococcus pneumoniae isolates in North America (2002-2003): Contemporary in vitro activities of amoxicillin/clavulanate and 15 other antimicrobial agents

International Journal of Antimicrobial Agents

Volumn 25, Issue 4, 2005, Pages 282-289

  Pottumarthy, Sudha ^a   Fritsche, Thomas R ^a   Sader, Helio S ^a   Stilwell, Matthew G ^a   Jones, Ronald N ^a,b  

^a JMI LABORATORIES   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amoxicillin clavulanate; North America; Resistance; S. pneumoniae

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIINFECTIVE AGENT; AUGMENTIN XR; AZITHROMYCIN; CEFDINIR; CEFPODOXIME; CEFPROZIL; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; ES 600; LEVOFLOXACIN; MACROLIDE; PENICILLIN G; SULFAMETHOXAZOLE; TETRACYCLINE; TRIMETHOPRIM; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DRUG ACTIVITY; DRUG ELIMINATION; DRUG FORMULARY; DRUG POTENCY; EMPIRICISM; HEALTH SURVEY; HUMAN; IN VITRO STUDY; INFANT; INFECTION SENSITIVITY; NONHUMAN; NORTH AMERICA; PENICILLIN RESISTANCE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

EID: 15244340395     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2004.12.001     Document Type: Article

References (22)

1. C.G. Whitney, M.M. Farley, and J. Hadler Active Bacterial Core Surveillance Program of the Emerging Infections Program Network. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States New Engl J Med 343 2000 1917 1924
2. A.W. McCormick, C.G. Whitney, and M.M. Farley Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States Nature Med 9 2003 424 430
3. E.L. Neurmberger, and W.R. Bishai Antibiotic resistance in Streptococcus pneumoniae: what does the future hold? Clin Infect Dis 38 2004 S363 S371
4. S.L. Kaplan, E.O. Mason Jr., and E.R. Wald Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine Pediatrics 113 2004 443 449
5. L.A. Mandell, J.G. Bartlett, S.F. Dowell, T.M. File Jr., D.M. Musher, and C. Whitney Infectious Diseases Society of America. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults Clin Infect Dis 37 2003 1405 1433
6. GlaxoSmithKline Prescribing information for Augmentin ES-600®. Available from URL: http://us.gsk.com/products/assets/us_augmentin_es600.pdf. AE:L9. GSK, Research Triangle Park, NC 27709, 2004.
7. GlaxoSmithKline Prescribing information for Augmentin XR™ Available from URL: http://us.gsk.com/products/assets/us_augmentin_xr.pdf. AX:L6. GSK, Research Triangle Park, NC 27709, 2004.
8. ® (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent J Antimicrob Chemother 53 2004 S1, i3-i20
9. K.A. Gordon, D.J. Biedenbach, and R.N. Jones Comparison of Streptococcus pneumoniae and Haemophilus influenzae susceptibilities from community-acquired respiratory infections and hospitalized patients with pneumonia: five-year results for the SENTRY Antimicrobial Surveillance Program Diagn Microbiol Infect Dis 46 2003 285 289
10. J.A. Karlowsky, C. Thornsberry, M.E. Jones, A.T. Evangelista, I.A. Critchley, and D.F. Sahm Factors associated with relative rates of antimicrobial resistance among Streptococcus pneumoniae in the United States: results from the TRUST Surveillance Program (1998-2002) Clin Infect Dis 36 2003 963 970
11. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A6. Wayne, PA: NCCLS; 2003.
12. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing, 14th informational supplement M100-S14. Wayne, PA: NCCLS; 2004.
13. D.K. Chen, A. McGeer, J.C. de Azavedo, and D.E. Low Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada New Engl J Med 341 1999 233 239
14. M.R. Jacobs, D. Felmingham, P.C. Appelbaum, R.N. Grüneberg the Alexander Project Group The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents J Antimicrob Chemother 52 2003 229 246
15. M.S. Niederman, L.A. Mandell, and A. Anzueto American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention Am J Respir Crit Care Med 163 2001 1730 1754
16. S.F. Dowell, J.C. Butler, and G.S. Giebink Acute otitis media: management and surveillance in the era of pneumococcal resistance - a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group Ped Infect Dis J 18 1999 1 9
17. W.C. Albrich, D.L. Monnet, and S. Harbarth Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes Emerg Infect Dis 10 2004 514 517
18. R.N. Jones, H.S. Sader, and T.R. Fritsche Doxycycline use for community-acquired pneumonia: contemporary in vitro spectrum of activity against Streptococcus pneumoniae (1999-2002) Diagn Microbiol Infect Dis 49 2004 147 149
19. M.E. Jones, J.A. Karlowsky, D.C. Draghi, C. Thornsberry, D.F. Sahm, and J.S. Bradley Rates of antimicrobial resistance among common bacterial pathogens causing respiratory, blood, urine and skin and soft tissue infections in pediatric patients Eur J Clin Microbiol Infect Dis 23 2004 445 455
20. R.N. Jones, D.J. Biedenbach, and M.L. Beach Influence of patient age on the susceptibility patterns of Streptococcus pneumoniae isolates in North America, (2000-2001): report from the SENTRY Antimicrobial Surveillance Program Diagn Microbiol Infect Dis 46 2003 77 80
21. J.A. Karlowsky, C. Thornsberry, and I.A. Crtichley Susceptibilities to levofloxacin in Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis clinical isolates from children: results from 2000-2001 and 2001-2002 TRUST studies in the United States Antimicrob Agents Chemother 47 2003 1790 1797
22. M.A. Pfaller, A.F. Ehrhardt, and R.N. Jones Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the Respiratory Surveillance Program Study: microbiology from the medical office practice environment Am J Med 111 2001 4S 12S